Milk Thistle: A Potent Natural Support for Liver Health and Detoxification
Milk Thistle is a herb native to Mediterranean countries, known for its liver-supporting properties It contains a group of flavonoids called silymarin, which exhibit antioxidant and anti-inflammatory effects.
Supplement Summary
| Name | Milk Thistle |
|---|---|
| Category | Herbs & Botanicals |
| Main Uses |
|
| Effectiveness | High |
| Common Dosage | 150-200 mg per day |
| Price Range | $-$$ |
| Forms Available | Capsules Tablets Liquid Extract |
Pros
- ✅ Supports liver health
- ✅ Helps detoxify the body
- ✅ Possesses antioxidant properties
- ✅ Stimulates liver cells regeneration
- ✅ Inhibits the binding of toxins to the liver cells
Cons / Side Effects
- ❌ May cause mild stomach upset
- ❌ Allergic reactions in people sensitive to the Asteraceae/Compositae plant family
- ❌ May interact with certain medications
What Is Milk Thistle?
How It Works
Who It's Best For
Who Should Avoid It
Dosage & Usage Tips
Buying Advice & Quality Tips
Price & Value
Final Verdict
Additional Clinical Research
RESEARCH SUMMARY: Milk Thistle
KEY FINDINGS:
Liver Disease Treatment
- A systematic review and meta-analysis of 14 randomized placebo-controlled trials involving 433 participants found that milk thistle did not significantly reduce mortality or improve liver histology and biochemical markers in patients with chronic liver disease.
- Study details: The analysis included trials assessing outcomes such as mortality, liver biopsy histology, serum aminotransferase levels, and prothrombin times.
Source: Jacobs et al. (2002)
Hepatotoxicity in Childhood Acute Lymphoblastic Leukemia
- A randomized, controlled, double-blind pilot study involving 50 children with acute lymphoblastic leukemia (ALL) and liver toxicity found that milk thistle was associated with a trend toward significant reductions in liver toxicity. At day 56, the milk thistle group had a significantly lower aspartate aminotransferase (AST) level (p=0.05) and a trend toward a lower alanine aminotransferase (ALT) level (p=0.07).
- Study details: Participants were randomized to receive milk thistle or placebo orally for 28 days, with liver function tests evaluated during the study period.
Source: Ladas et al. (2010)
Antituberculosis Drug-Induced Liver Injury
- A meta-analysis of five randomized controlled trials involving 1,198 patients found that prophylactic therapy with silymarin (milk thistle) significantly reduced the occurrence of antituberculosis drug-induced liver injury (anti-TB DILI) at week 4 (RR: 0.33, 95% CI: 0.15 to 0.75). Silymarin also improved liver function markers, including ALT, AST, and ALP levels.
- Study details: The analysis included trials comparing silymarin and placebo for the prevention of anti-TB DILI, assessing outcomes such as liver enzyme levels and adverse events.
Source: Tao et al. (2019)
RESEARCH QUALITY ASSESSMENT:
- The studies included were randomized controlled trials and meta-analyses, providing a high level of evidence.
- Sample sizes varied, with some studies having limited participants, which may affect the generalizability of the findings.
- Some studies reported trends toward significance rather than definitive results, indicating the need for larger, more robust trials.
- Further research is needed to determine the optimal dosing, duration, and patient populations that may benefit most from milk thistle supplementation.


